about
Histamine and Immune Biomarkers in CNS DisordersThe expanding role of immunopharmacology: IUPHAR Review 16International Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsDOGS: reaction-driven de novo design of bioactive compoundsHistamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuseHistamine receptors and cancer pharmacology.H3 receptors and pain modulation: peripheral, spinal, and brain interactions.Molecular and cellular mechanisms that initiate pain and itch.Role of histamine and its receptors in cerebral ischemiaTherapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.Recent advances in histamine H3 receptor antagonists/inverse agonists.The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010.The role of the histamine H4 receptor in atopic dermatitis.Insights into the physiomodulatory role of histaminergic receptors in vertebrate skin pigmentation.New H1/H3 antagonists for treating allergic rhinitis: WO2010094643.Histamine pharmacology and new CNS drug targets.Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.Update in clinical allergy and immunology.Qsar Modeling Of Histamine H3r Antagonists/Inverse Agonists As Future Drugs For Neurodegenerative Diseases.Regulation of the Cardiovascular System by Histamine.Increased expression of the histamine H4 receptor subtype in hypertrophic differentiation of chondrogenic ATDC5 cells.Expression and functional properties of canine, rat, and murine histamine H₄ receptors in Sf9 insect cells.Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376.Activation of histamine H4 receptor inhibits TNFα/IMD-0354-induced apoptosis in human salivary NS-SV-AC cells.Modulation of metabolic activity of phagocytes by antihistamines.Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands.Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.Overdose of the histamine H₃ inverse agonist pitolisant increases thermal pain thresholds.1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H3 R/H4 R.Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics.Anti-inflammatory effect of a new piperazine derivative: (4-methylpiperazin-1-yl)(1-phenyl-1H-pyrazol-4-yl)methanone.Histamine down-regulates IL-27 production in antigen-presenting cells.Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report.Lower expression of histamine H₄ receptor in synovial tissues from patients with rheumatoid arthritis compared to those with osteoarthritis.
P2860
Q26748803-95D919C0-0F7B-4D9F-92E1-41518D464DEFQ26801862-0C332AB8-92F8-4417-BAD7-3684C4037511Q26827568-71ECF07E-226F-491B-896F-EECCD366429AQ28480868-83698586-60F9-4162-9EDA-C1F817880A15Q30462161-590695D4-2A65-4691-988B-CA8D83A2F632Q34356076-7D6BD23E-03D2-4012-A4D3-E8D1E45B8AD9Q34458579-A7C5D9E4-F7F2-41E6-888A-9ADD2E580CAAQ35946504-492BC106-4F73-4908-919D-9D381FAD0CC7Q36015593-D88A267B-F502-405E-9163-100CF746C223Q37151169-FF31EBF5-37C4-4E71-A0BA-89EEBA3F7C36Q37780549-C93191BC-BC61-4E82-BD77-02DB48AA6258Q37780551-9F7394DB-BA41-409C-BFB6-5838FA1A61B2Q37811985-42932016-18C6-459E-BA02-5D49B5DAE6B7Q37841605-B4FADE19-5DA2-4D93-A1BD-19B1B427B699Q37845843-850F3578-ACC0-4BBB-8D77-CAB32644B3B0Q37954375-72187292-986D-452E-9E22-5C895C019EC0Q38023551-85E4860E-7F0C-4178-8CE6-0366F67331F7Q38056516-987F79AE-ADB1-42FA-AB40-7E6DD48ECE41Q38640425-0C5C807F-FA77-4AA9-9DE3-4B5D872874A9Q39006801-E5FA0AEF-9A19-4795-9C1C-C1746457815CQ39446597-F950C6C4-C9C4-4834-A189-EEF35235ECFEQ39584467-77AC900C-082C-4463-AD90-76D67CB6B41FQ42004904-4B01F7B2-DF65-4829-9B41-AA687AD014C1Q42015639-9415498C-A1F1-4E80-AE1C-F333DA0154C1Q42186694-95DCCBE2-7A37-490B-9B82-F6AFB2A81120Q42729017-512524C2-2B81-4C22-82FE-744C1E5057FAQ42921406-A8B848BD-71C9-4130-B62F-F02E867DE91CQ47102892-074DA2D5-BBDB-45CD-946A-78600961527FQ47356761-1934490A-6242-46AB-BEDB-CE774F2C2D45Q48327394-AF69536B-D877-4B74-9D87-98C28BE31D25Q48812098-FE7AB5C8-E66E-481F-A887-068DF0D54A05Q50199813-97CB8324-89F9-49F5-B8DE-06FB2B0255A9Q53181526-ACDAEBDC-0DF2-4BC6-8627-E98ED48C6BECQ53185082-51DE12D9-7686-4187-9320-4A9E3984AC5AQ54351151-67F137B4-0C46-42DB-8355-054E84E9514A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histamine H3 and H4 receptors as novel drug targets.
@en
Histamine H3 and H4 receptors as novel drug targets.
@nl
type
label
Histamine H3 and H4 receptors as novel drug targets.
@en
Histamine H3 and H4 receptors as novel drug targets.
@nl
prefLabel
Histamine H3 and H4 receptors as novel drug targets.
@en
Histamine H3 and H4 receptors as novel drug targets.
@nl
P2093
P2860
P1476
Histamine H3 and H4 receptors as novel drug targets
@en
P2093
Ekaterini Tiligada
Holger Stark
Kerstin Sander
P2860
P304
P356
10.1517/14728220903188438
P407
P577
2009-10-01T00:00:00Z